[PDF] Top 20 Biogenic nanosilver against multidrug-resistant bacteria (MDRB)

... to nanosilver, despite the good performance of AgNPs against a range of bacterial strains, as already ...typhimurium resistant to silver nitrate, mercuric chloride, and a range of common antibiotics ... See full document

... The antibacterial activity of plant extracts of the Lamiaceae family was evaluated against clinical isolates of multi-resistant Gram-negative bacteria by broth microdilution technique. Promising ... See full document

... The global spread of extended-spectrum β-lactamase (ESBL) producing enterobacteria has re- sulted in a worldwide increase in carbapenem consumption. This selective pressure has fos- tered the emergence and spread of ... See full document

... mixed charged zwitterion-modified AuNPs consisting of a weak electrolytic 11-mercaptoundecanoic acid (HS-C10-COOH) and a strong electrolytic (10-mercaptodecyl)trimethylammonium bromide (HS-C10-N4) that exhibited in vivo ... See full document

... agents against multi-drug resistant (MDR) bacteria was ...assayed against a set of seven clinically isolated MDR bacteria, including three Staphylococcus aureus ...agents against ... See full document

... Intrinsic resistance of M. tuberculosis to antimicrobial agents is mainly attributed to the reduced permeability of the cell wall due to the lipid-rich composition and the presence of mycolic acids that considerably ... See full document

... and bacteria can interact direct- ly by fusion processes, leading to the release of the encap- sulated antibiotic within the bacteria (Sachetelli et ...liposomes against Mycobacterium bovis was ... See full document

... activity against S. aureus and did not display antimicrobial activity against another Gram-positive bacterium such as Enterococcus faecium or the Gram-negative bacteria Klebisella pneumoniae, ... See full document

... LB 11058 is a novel parenteral cephalosporin with a C-3 pyrimidinyl-substituted vinyl sulfide group and a C-7 2-amino- 5-chloro-1,3-thiazole group (Fig. 1). Preliminary studies have indicated that this compound has ... See full document

... of multidrug-resistant bac- teria has made the search for new antimicrobial agents an important strategy in the establishment of alterna- tive therapies for difficult-to-manage infections (Rice ...instance, ... See full document

... In addition, K. pneumoniae is a frequent cause of nosocomial infections and has also emerged as an agent of severe community-acquired infections, including pyogenic liver abscess, pneumonia, and meningitis (22). ... See full document

... partial characterization of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA). ... See full document

... groups. Bacteria were isolated in 45 ...efficacy) against the pathogens in the disk diffusion ...were resistant to three or more different pharmacological groups and were considered multidrug ... See full document

... investigated against multidrug-resistant ...out against 29 ...activity against microorganisms with multidrug-resistant ... See full document

... 39. Chin NX, Weitzman I. In vitro activity of fluvastatin, a cholesterol- lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans. Antimicrob Agents ... See full document

... determined against each time interval for different dilutions of disinfectants and statistically ...most resistant (Figure-1), Lysol showed least efficacy among Acinetobacter baumanii (Figure-2), Novacide ... See full document

... of bacteria isolated from intensive care unit (ICU) patient ...for bacteria isolates was determined by the E-test ...the bacteria most frequently isolated from the blood, CSF and urine samples, ... See full document

... Gram-negative bacteria is in the cell wall. While Gram-positive bacteria have a dense peptidoglycan layer, composed of multiple individual layers of peptidoglycan enclosing cell membrane, Gram-negative ... See full document

... How to Resolve the Impasse Recent developments in MDR-TB epidemiology, treatment programs, clinical trials methodology, and TB drug development suggest an end to the present impasse. First, the magnitude of the MDR-TB ... See full document

... The authors used whole-genome sequencing to determine genetic changes occurring during monotherapy versus sequential treatments and found that both treatments promoted the am- plification of the multidrug efflux ... See full document